Key facts
- Curative’s last known valuation is $1.3B (Nov 2025).
- It has raised $161.3M across 1 recorded rounds; the latest was Later Stage VC ($152.5M) in Oct 2025.
- Notable investors include Soma Capital, DCVC, Refactor Capital, Justin Mateen, Saraswati Ventures — 16 tracked in total.
- Curative has filed 1 Form D with the SEC, most recently Dec 2025 ($152.5M sold to 12 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 16 names
- ·Watchlist + deal alerts for Curative
Funding rounds
1 roundsAbout Curative
Provider of health insurance services intended to make essential healthcare easier to access for everyone. The company's service offerings include COVID-19 testing through a painless and self-administered oral fluid swab, vaccinations, baseline visits, curative commons, and virtual urgent care, enabling clients to access health insurance by providing unmatched simplicity, enhanced engagement, and cost transparency with a competitive monthly premium.
- Sector
- Healthcare
- HQ
- Austin, TX, United States
- Founded
- 2020
- Employees
- 2,800
- Website
- curative.com/
- Ownership
- Privately Held (backing)
Curative doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Curative shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Curative in its N-PORT filings yet. We sweep new filings monthly.